OBJECTIVEAbnormal glucose tolerance is rising in sub-Saharan Africa. Hemoglobin A(1c) by itself and in combination with fasting plasma glucose (FPG) is used to diagnose abnormal glucose tolerance. The diagnostic ability of A1C in Africans with heterozygous variant hemoglobin, such as sickle cell trait or hemoglobin C trait, has not been rigorously evaluated. In U.S.-based Africans, we determined by hemoglobin status the sensitivities of 1) FPG 5.6 mmol/L, 2) A1C 5.7% (39 mmol/mol), and 3) FPG combined with A1C (FPG 5.6 mmol/L and/or A1C 5.7% [39 mmol/mol]) for the detection of abnormal glucose tolerance.RESEARCH DESIGN AND METHODSAn oral glucose tolerance test (OGTT) was performed in 216 African immigrants (68% male, age 37 10 years [mean SD], range 20-64 years). Abnormal glucose tolerance was defined as 2-h glucose 7.8 mmol/L.RESULTSVariant hemoglobin was identified in 21% (46 of 216). Abnormal glucose tolerance occurred in 33% (72 of 216). When determining abnormal glucose tolerance from the OGTT (2-h glucose 7.8 mmol/L), sensitivities of FPG for the total, normal, and variant hemoglobin groups were 32%, 32%, and 33%, respectively. Sensitivities for A1C were 53%, 54%, and 47%. For FPG and A1C combined, sensitivities were 64%, 63%, and 67%. Sensitivities for FPG and A1C and the combination did not vary by hemoglobin status (all P > 0.6). For the entire cohort, sensitivity was higher for A1C than FPG and for both tests combined than for either test alone (all P values 0.01).CONCLUSIONSNo significant difference in sensitivity of A1C by variant hemoglobin status was detected. For the diagnosis of abnormal glucose tolerance in Africans, the sensitivity of A1C combined with FPG is significantly superior to either test alone.